View Future GrowthGVS 過去の業績過去 基準チェック /36GVSの収益は年間平均-37.1%の割合で減少していますが、 Medical Equipment業界の収益は年間 減少しています。収益は年間20.3% 4%割合で 増加しています。 GVSの自己資本利益率は6.1%であり、純利益率は6.6%です。主要情報-37.14%収益成長率-38.27%EPS成長率Medical Equipment 業界の成長8.28%収益成長率4.00%株主資本利益率6.14%ネット・マージン6.62%次回の業績アップデート06 Aug 2026最近の業績更新分析記事 • May 25GVS' (BIT:GVS) Earnings Seem To Be PromisingThe market seemed underwhelmed by last week's earnings announcement from GVS S.p.A. ( BIT:GVS ) despite the healthy...Reported Earnings • Apr 29Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €0.098 (down from €0.19 in FY 2024). Revenue: €424.7m (flat on FY 2024). Net income: €18.4m (down 45% from FY 2024). Profit margin: 4.3% (down from 7.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.分析記事 • Nov 23We Like GVS' (BIT:GVS) Earnings For More Than Just Statutory ProfitGVS S.p.A.'s ( BIT:GVS ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...Reported Earnings • Nov 14Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: €104.8m (down 1.9% from 3Q 2024). Net income: €7.98m (up €7.46m from 3Q 2024). Profit margin: 7.6% (up from 0.5% in 3Q 2024). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Italy.Reported Earnings • Aug 10Second quarter 2025 earnings released: €0.005 loss per share (vs €0.055 profit in 2Q 2024)Second quarter 2025 results: €0.005 loss per share (down from €0.055 profit in 2Q 2024). Revenue: €112.1m (up 1.2% from 2Q 2024). Net loss: €880.0k (down 109% from profit in 2Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 20% per year.分析記事 • May 24Shareholders Will Be Pleased With The Quality of GVS' (BIT:GVS) EarningsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week was disappointing for investors, despite the decent profit...すべての更新を表示Recent updatesナラティブの更新 • Jun 26GVS: Share Buyback Program Will Support Future Upside PotentialAnalysts have trimmed their price target for GVS to €5.14 from €5.98. This reflects updated assumptions for slightly lower revenue growth, profit margins and fair value, alongside a modestly reduced discount rate and a near unchanged future P/E.New Risk • Jun 09New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Large one-off items impacting financial results.分析記事 • May 25GVS' (BIT:GVS) Earnings Seem To Be PromisingThe market seemed underwhelmed by last week's earnings announcement from GVS S.p.A. ( BIT:GVS ) despite the healthy...Reported Earnings • Apr 29Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €0.098 (down from €0.19 in FY 2024). Revenue: €424.7m (flat on FY 2024). Net income: €18.4m (down 45% from FY 2024). Profit margin: 4.3% (down from 7.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €4.20, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 17x in the Medical Equipment industry in Italy. Total loss to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €4.83 per share.New Risk • Mar 30New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 42% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (42% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.3% net profit margin).分析記事 • Mar 29GVS S.p.A. (BIT:GVS) Just Reported, And Analysts Assigned A €5.16 Price TargetIt's been a good week for GVS S.p.A. ( BIT:GVS ) shareholders, because the company has just released its latest...Buy Or Sell Opportunity • Mar 16Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to €3.43. The fair value is estimated to be €4.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.6% over the last 3 years. Earnings per share has declined by 5.4%. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 122% in the next 2 years.New Risk • Nov 29New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 56% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (56% net debt to equity). Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results.分析記事 • Nov 23We Like GVS' (BIT:GVS) Earnings For More Than Just Statutory ProfitGVS S.p.A.'s ( BIT:GVS ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...分析記事 • Nov 15Earnings Report: GVS S.p.A. Missed Revenue Estimates By 8.1%Investors in GVS S.p.A. ( BIT:GVS ) had a good week, as its shares rose 3.0% to close at €4.33 following the release of...Reported Earnings • Nov 14Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: €104.8m (down 1.9% from 3Q 2024). Net income: €7.98m (up €7.46m from 3Q 2024). Profit margin: 7.6% (up from 0.5% in 3Q 2024). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Italy.New Risk • Nov 13New major risk - Revenue and earnings growthEarnings have declined by 35% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).New Risk • Oct 23New major risk - Revenue and earnings growthEarnings have declined by 35% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).分析記事 • Oct 23GVS (BIT:GVS) Will Want To Turn Around Its Return TrendsWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Major Estimate Revision • Oct 22Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €448.1m to €443.3m. EPS estimate also fell from €0.112 per share to €0.101 per share. Net income forecast to grow 136% next year vs 19% growth forecast for Medical Equipment industry in Italy. Consensus price target down from €6.23 to €6.05. Share price fell 9.9% to €4.19 over the past week.分析記事 • Sep 16Calculating The Fair Value Of GVS S.p.A. (BIT:GVS)Key Insights Using the 2 Stage Free Cash Flow to Equity, GVS fair value estimate is €4.64 With €4.97 share price, GVS...New Risk • Sep 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).分析記事 • Aug 10GVS S.p.A. (BIT:GVS) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?BIT:GVS 1 Year Share Price vs Fair Value Explore GVS's Fair Values from the Community and select yours It's been a good...Reported Earnings • Aug 10Second quarter 2025 earnings released: €0.005 loss per share (vs €0.055 profit in 2Q 2024)Second quarter 2025 results: €0.005 loss per share (down from €0.055 profit in 2Q 2024). Revenue: €112.1m (up 1.2% from 2Q 2024). Net loss: €880.0k (down 109% from profit in 2Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 20% per year.Major Estimate Revision • Jul 11Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €458.6m to €452.6m. EPS estimate also fell from €0.27 per share to €0.196 per share. Net income forecast to grow 66% next year vs 24% growth forecast for Medical Equipment industry in Italy. Consensus price target of €6.38 unchanged from last update. Share price fell 3.8% to €5.35 over the past week.お知らせ • Jul 08GVS S.p.A. (BIT:GVS) commences an Equity Buyback Plan for 37,835,539 shares, representing 20% of its issued share capital, under the authorization approved on May 8, 2025.GVS S.p.A. (BIT:GVS) commences a share repurchases on July 1, 2025, under the program mandated by the shareholders in the Ordinary General Meeting held on May 8, 2025. As per the mandate, the company is authorized to repurchase 37,835,539 shares in such a way that the maximum number of shares purchased may not have a total nominal value in excess of 20% of the company’s share capital. The shares will be repurchased at a unit price of not lower than 20% below and not higher than 10% above the reference price that the share will have recorded in the trading session of the day preceding each individual transaction. The purpose of the program is to support market liquidity and efficiency, for holding and subsequent use, including, payment in extraordinary transactions and for the use in service of compensation plans based on financial instruments. The authorization will be valid for a period of 18 months. As of March 24, 2025, the company had 189,177,693 shares in outstanding and held no shares in treasury. On June 30, 2025, the company announced a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.1% of the share capital, for €20 million. The program will commence from July 1, 2025 and will run through December 31, 2025.Buy Or Sell Opportunity • Jun 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to €4.84. The fair value is estimated to be €3.95, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.2% over the last 3 years. Earnings per share has declined by 31%. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 114% in the next 2 years.分析記事 • Jun 11Here's Why GVS (BIT:GVS) Can Manage Its Debt ResponsiblyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • May 24Shareholders Will Be Pleased With The Quality of GVS' (BIT:GVS) EarningsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week was disappointing for investors, despite the decent profit...New Risk • May 22New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 50% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (50% net debt to equity). Large one-off items impacting financial results.Reported Earnings • Apr 21Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: €0.19 (up from €0.078 in FY 2023). Revenue: €428.5m (flat on FY 2023). Net income: €33.4m (up 145% from FY 2023). Profit margin: 7.8% (up from 3.2% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 18%. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Mar 28Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €4.12, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 12x in the Machinery industry in Italy. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €3.26 per share.分析記事 • Mar 28Should You Think About Buying GVS S.p.A. (BIT:GVS) Now?GVS S.p.A. ( BIT:GVS ), might not be a large cap stock, but it received a lot of attention from a substantial price...分析記事 • Feb 24These 4 Measures Indicate That GVS (BIT:GVS) Is Using Debt Reasonably WellThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...お知らせ • Feb 22GVS S.p.A. to Report Q3, 2025 Results on Nov 12, 2025GVS S.p.A. announced that they will report Q3, 2025 results on Nov 12, 2025お知らせ • Feb 21+ 2 more updatesGVS S.p.A. to Report Fiscal Year 2024 Results on Mar 24, 2025GVS S.p.A. announced that they will report fiscal year 2024 results on Mar 24, 2025分析記事 • Feb 08Calculating The Fair Value Of GVS S.p.A. (BIT:GVS)Key Insights The projected fair value for GVS is €4.49 based on 2 Stage Free Cash Flow to Equity With €4.54 share...New Risk • Jan 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (87% net debt to equity). Share price has been volatile over the past 3 months (5.5% average weekly change). Large one-off items impacting financial results.お知らせ • Jan 15GVS S.p.A. (BIT:GVS) completed the acquisition of Whole Blood Assets within Blood Center Business from Haemonetics Corporation (NYSE:HAE).GVS S.p.A. (BIT:GVS) entered into a definitive agreement to acquire Whole Blood Assets within Blood Center Business from Haemonetics Corporation (NYSE:HAE) for $67.8 million on December 3, 2024. The transaction comprises a total cash consideration of up to $67.8 million, including $45.3 million upfront after giving effect to certain customary adjustments, and up to $22.5million in contingent earn-outs over the next four years. Haemonetics Corporation intends to use the proceeds from this transaction for general corporate purposes and additional investments in growth initiatives. The Transaction will be funded using available cash resources. This transaction is subject to the satisfaction of customary closing conditions and is expected to close in the first quarter of calendar 2025. Banca Sella Holding S.p.A.acted as sole financial advisor and Cleary Gottlieb Steen & Hamilton LLP acted as legal counsel to GVS. GVS S.p.A. (BIT:GVS) completed the acquisition of Whole Blood Assets within Blood Center Business from Haemonetics Corporation (NYSE:HAE) on December 3, 2024.分析記事 • Jan 11Revenues Tell The Story For GVS S.p.A. (BIT:GVS)GVS S.p.A.'s ( BIT:GVS ) price-to-sales (or "P/S") ratio of 1.9x may not look like an appealing investment opportunity...分析記事 • Dec 22What Is GVS S.p.A.'s (BIT:GVS) Share Price Doing?While GVS S.p.A. ( BIT:GVS ) might not have the largest market cap around , it saw significant share price movement...Buy Or Sell Opportunity • Dec 18Now 21% overvaluedOver the last 90 days, the stock has fallen 20% to €5.20. The fair value is estimated to be €4.28, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 254% in the next 2 years.分析記事 • Dec 07Returns On Capital Signal Tricky Times Ahead For GVS (BIT:GVS)If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...分析記事 • Nov 22GVS' (BIT:GVS) Solid Earnings Are Supported By Other Strong FactorsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week was disappointing for investors, despite the decent profit...Reported Earnings • Nov 17Third quarter 2024 earnings released: EPS: €0.003 (vs €0.049 in 3Q 2023)Third quarter 2024 results: EPS: €0.003 (down from €0.049 in 3Q 2023). Revenue: €111.5m (up 12% from 3Q 2023). Net income: €519.0k (down 94% from 3Q 2023). Profit margin: 0.5% (down from 8.5% in 3Q 2023). Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.分析記事 • Oct 23GVS S.p.A. (BIT:GVS) Shares Could Be 34% Above Their Intrinsic Value EstimateKey Insights GVS' estimated fair value is €4.67 based on 2 Stage Free Cash Flow to Equity GVS is estimated to be 34...分析記事 • Oct 02Getting In Cheap On GVS S.p.A. (BIT:GVS) Is UnlikelyWhen close to half the companies in the Machinery industry in Italy have price-to-sales ratios (or "P/S") below 0.7x...New Risk • Sep 13New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.9x net interest cover). Minor Risk Large one-off items impacting financial results.Reported Earnings • Sep 13Second quarter 2024 earnings released: EPS: €0.056 (vs €0.027 in 2Q 2023)Second quarter 2024 results: EPS: €0.056 (up from €0.027 in 2Q 2023). Revenue: €114.7m (up 4.9% from 2Q 2023). Net income: €9.58m (up 100% from 2Q 2023). Profit margin: 8.4% (up from 4.4% in 2Q 2023). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance.分析記事 • Sep 04Returns On Capital At GVS (BIT:GVS) Paint A Concerning PictureFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...お知らせ • Jul 26+ 2 more updatesGVS S.p.A. to Report Q3, 2024 Results on Nov 14, 2024GVS S.p.A. announced that they will report Q3, 2024 results on Nov 14, 2024分析記事 • Jun 28Is GVS (BIT:GVS) A Risky Investment?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Price Target Changed • Jun 10Price target increased by 9.4% to €6.97Up from €6.37, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of €7.00. Stock is up 14% over the past year. The company is forecast to post earnings per share of €0.22 for next year compared to €0.078 last year.分析記事 • Jun 09Investors Appear Satisfied With GVS S.p.A.'s (BIT:GVS) Prospects As Shares Rocket 28%GVS S.p.A. ( BIT:GVS ) shares have had a really impressive month, gaining 28% after a shaky period beforehand. Taking a...分析記事 • Jun 08Should You Investigate GVS S.p.A. (BIT:GVS) At €7.00?GVS S.p.A. ( BIT:GVS ), is not the largest company out there, but it led the BIT gainers with a relatively large price...New Risk • Jun 04New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 76% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (76% net debt to equity). Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €6.90, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €3.72 per share.Reported Earnings • May 16First quarter 2024 earnings released: EPS: €0.074 (vs €0.015 in 1Q 2023)First quarter 2024 results: EPS: €0.074 (up from €0.015 in 1Q 2023). Revenue: €105.2m (up 1.1% from 1Q 2023). Net income: €13.0m (up 411% from 1Q 2023). Profit margin: 12% (up from 2.4% in 1Q 2023). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.お知らせ • Apr 24GVS S.p.A. to Report Q1, 2024 Results on May 14, 2024GVS S.p.A. announced that they will report Q1, 2024 results on May 14, 2024分析記事 • Apr 21Earnings Tell The Story For GVS S.p.A. (BIT:GVS)With a price-to-earnings (or "P/E") ratio of 72.7x GVS S.p.A. ( BIT:GVS ) may be sending very bearish signals at the...Major Estimate Revision • Apr 14Consensus EPS estimates increase by 27%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from €0.182 to €0.231. Revenue forecast steady at €445.0m. Net income forecast to grow 195% next year vs 9.1% growth forecast for Machinery industry in Italy. Consensus price target of €6.37 unchanged from last update. Share price fell 2.9% to €5.96 over the past week.分析記事 • Apr 03Some Investors May Be Willing To Look Past GVS' (BIT:GVS) Soft EarningsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week didn't impress shareholders. Despite the soft profit numbers...New Risk • Mar 30New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 51% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).分析記事 • Mar 29GVS S.p.A. (BIT:GVS) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This YearThere's been a notable change in appetite for GVS S.p.A. ( BIT:GVS ) shares in the week since its yearly report, with...New Risk • Mar 28New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.5x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (3.1% net profit margin).分析記事 • Mar 26Capital Allocation Trends At GVS (BIT:GVS) Aren't IdealIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...お知らせ • Feb 26GVS S.p.A. to Report Fiscal Year 2023 Results on Mar 26, 2024GVS S.p.A. announced that they will report fiscal year 2023 results on Mar 26, 2024分析記事 • Feb 23GVS (BIT:GVS) Has A Pretty Healthy Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Dec 15Be Wary Of GVS (BIT:GVS) And Its Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...Reported Earnings • Nov 12Third quarter 2023 earnings released: EPS: €0.048 (vs €0.072 in 3Q 2022)Third quarter 2023 results: EPS: €0.048 (down from €0.072 in 3Q 2022). Revenue: €104.4m (down 2.6% from 3Q 2022). Net income: €8.49m (down 33% from 3Q 2022). Profit margin: 8.1% (down from 12% in 3Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 135 percentage points per year, which is a significant difference in performance.お知らせ • Oct 11GVS S.p.A. to Report Q3, 2023 Results on Nov 09, 2023GVS S.p.A. announced that they will report Q3, 2023 results on Nov 09, 2023分析記事 • Sep 27GVS S.p.A. (BIT:GVS) Shares Could Be 33% Above Their Intrinsic Value EstimateKey Insights GVS' estimated fair value is €3.60 based on 2 Stage Free Cash Flow to Equity GVS is estimated to be 33...Reported Earnings • Sep 07Second quarter 2023 earnings released: EPS: €0.025 (vs €0.11 in 2Q 2022)Second quarter 2023 results: EPS: €0.025 (down from €0.11 in 2Q 2022). Revenue: €111.9m (up 31% from 2Q 2022). Net income: €4.79m (down 76% from 2Q 2022). Profit margin: 4.3% (down from 23% in 2Q 2022). Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 127 percentage points per year, which is a significant difference in performance.お知らせ • Aug 08GVS S.p.A. to Report Q2, 2023 Results on Sep 05, 2023GVS S.p.A. announced that they will report Q2, 2023 results on Sep 05, 2023分析記事 • Aug 02GVS (BIT:GVS) Might Be Having Difficulty Using Its Capital EffectivelyWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Price Target Changed • May 23Price target increased by 8.7% to €6.63Up from €6.10, the current price target is an average from 4 analysts. New target price is 16% above last closing price of €5.72. Stock is down 24% over the past year. The company is forecast to post earnings per share of €0.19 for next year compared to €0.14 last year.Reported Earnings • May 16First quarter 2023 earnings released: EPS: €0.014 (vs €0.072 in 1Q 2022)First quarter 2023 results: EPS: €0.014 (down from €0.072 in 1Q 2022). Revenue: €105.0m (up 29% from 1Q 2022). Net income: €2.50m (down 80% from 1Q 2022). Profit margin: 2.4% (down from 16% in 1Q 2022). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Machinery industry in Italy.Price Target Changed • Apr 30Price target increased by 8.7% to €6.63Up from €6.10, the current price target is an average from 3 analysts. New target price is 7.4% above last closing price of €6.18. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.20 for next year compared to €0.14 last year.分析記事 • Apr 14Returns At GVS (BIT:GVS) Are On The Way UpIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Valuation Update With 7 Day Price Move • Mar 28Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €5.44, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 12x in the Machinery industry in Italy. Total loss to shareholders of 32% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €2.63 per share.Reported Earnings • Mar 22Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: €0.27 (down from €0.39 in FY 2021). Revenue: €392.0m (up 15% from FY 2021). Net income: €46.5m (down 31% from FY 2021). Profit margin: 12% (down from 20% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 38%. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Machinery industry in Italy.Price Target Changed • Jan 23Price target increased to €6.55Up from €5.50, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €5.04. Stock is down 46% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €0.39 last year.Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to €4.91, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 12x in the Machinery industry in Italy. Total loss to shareholders of 50% over the past year.Valuation Update With 7 Day Price Move • Dec 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to €4.02, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 62% over the past year.分析記事 • Dec 10GVS (BIT:GVS) Will Want To Turn Around Its Return TrendsThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 4 independent directors (5 non-independent directors). Executive Director Matteo Viola was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.分析記事 • Nov 11Calculating The Fair Value Of GVS S.p.A. (BIT:GVS)How far off is GVS S.p.A. ( BIT:GVS ) from its intrinsic value? Using the most recent financial data, we'll take a look...Valuation Update With 7 Day Price Move • Nov 10Investor sentiment deteriorated over the past weekAfter last week's 38% share price decline to €3.00, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 72% over the past year.Reported Earnings • Sep 11Second quarter 2022 earnings released: EPS: €0.11 (vs €0.096 in 2Q 2021)Second quarter 2022 results: EPS: €0.11 (up from €0.096 in 2Q 2021). Revenue: €85.3m (down 1.5% from 2Q 2021). Net income: €19.8m (up 18% from 2Q 2021). Profit margin: 23% (up from 19% in 2Q 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Machinery industry in Italy.Valuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €7.69, the stock trades at a trailing P/E ratio of 27.5x. Average forward P/E is 10x in the Machinery industry in Italy. Total loss to shareholders of 52% over the past year.分析記事 • Aug 30Here's What's Concerning About GVS' (BIT:GVS) Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...分析記事 • Jul 28At €9.05, Is GVS S.p.A. (BIT:GVS) Worth Looking At Closely?While GVS S.p.A. ( BIT:GVS ) might not be the most widely known stock at the moment, it saw a significant share price...分析記事 • Jul 13Investor Optimism Abounds GVS S.p.A. (BIT:GVS) But Growth Is LackingGVS S.p.A.'s ( BIT:GVS ) price-to-earnings (or "P/E") ratio of 30.4x might make it look like a strong sell right now...収支内訳GVS の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BIT:GVS 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Mar 2642228133031 Dec 2542518133030 Sep 2542223134030 Jun 2542915137031 Mar 2543226138031 Dec 2442933138030 Sep 2443317137030 Jun 2442625136031 Mar 2442521133031 Dec 2342514134030 Sep 23427-5134030 Jun 23434-1138031 Mar 2341014132031 Dec 2238824125030 Sep 2235556115030 Jun 2231652104031 Mar 2231849101031 Dec 2134068102030 Sep 2136477107030 Jun 2140899111031 Mar 21407101109031 Dec 2036578100030 Sep 203146491030 Jun 202584482031 Mar 202313276031 Dec 192293376030 Jun 192203272031 Mar 192142972031 Dec 182102372030 Jun 18245383031 Mar 18227277031 Dec 17166659030 Sep 17178760030 Jun 171451350031 Mar 171451349031 Dec 161441249030 Sep 161411049030 Jun 16138949031 Mar 16136948031 Dec 151349480質の高い収益: GVSには€17.3M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が31st March, 2026に影響を及ぼしています。利益率の向上: GVSの現在の純利益率 (6.6%)は、昨年(6%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: GVSの収益は過去 5 年間で年間37.1%減少しました。成長の加速: GVSの過去 1 年間の収益成長率 ( 8.4% ) は、5 年間の平均 ( 年間-37.1%を上回っています。収益対業界: GVSの過去 1 年間の収益成長率 ( 8.4% ) はMedical Equipment業界-27%を上回りました。株主資本利益率高いROE: GVSの 自己資本利益率 ( 6.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YHealthcare 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/30 21:09終値2026/06/30 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋GVS S.p.A. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Gabriele VenturiBanca Akros S.p.A. (ESN)Gerhard OrgonasBerenbergAnna FrontaniBerenberg4 その他のアナリストを表示
分析記事 • May 25GVS' (BIT:GVS) Earnings Seem To Be PromisingThe market seemed underwhelmed by last week's earnings announcement from GVS S.p.A. ( BIT:GVS ) despite the healthy...
Reported Earnings • Apr 29Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €0.098 (down from €0.19 in FY 2024). Revenue: €424.7m (flat on FY 2024). Net income: €18.4m (down 45% from FY 2024). Profit margin: 4.3% (down from 7.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
分析記事 • Nov 23We Like GVS' (BIT:GVS) Earnings For More Than Just Statutory ProfitGVS S.p.A.'s ( BIT:GVS ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...
Reported Earnings • Nov 14Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: €104.8m (down 1.9% from 3Q 2024). Net income: €7.98m (up €7.46m from 3Q 2024). Profit margin: 7.6% (up from 0.5% in 3Q 2024). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Italy.
Reported Earnings • Aug 10Second quarter 2025 earnings released: €0.005 loss per share (vs €0.055 profit in 2Q 2024)Second quarter 2025 results: €0.005 loss per share (down from €0.055 profit in 2Q 2024). Revenue: €112.1m (up 1.2% from 2Q 2024). Net loss: €880.0k (down 109% from profit in 2Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 20% per year.
分析記事 • May 24Shareholders Will Be Pleased With The Quality of GVS' (BIT:GVS) EarningsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week was disappointing for investors, despite the decent profit...
ナラティブの更新 • Jun 26GVS: Share Buyback Program Will Support Future Upside PotentialAnalysts have trimmed their price target for GVS to €5.14 from €5.98. This reflects updated assumptions for slightly lower revenue growth, profit margins and fair value, alongside a modestly reduced discount rate and a near unchanged future P/E.
New Risk • Jun 09New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Large one-off items impacting financial results.
分析記事 • May 25GVS' (BIT:GVS) Earnings Seem To Be PromisingThe market seemed underwhelmed by last week's earnings announcement from GVS S.p.A. ( BIT:GVS ) despite the healthy...
Reported Earnings • Apr 29Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €0.098 (down from €0.19 in FY 2024). Revenue: €424.7m (flat on FY 2024). Net income: €18.4m (down 45% from FY 2024). Profit margin: 4.3% (down from 7.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €4.20, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 17x in the Medical Equipment industry in Italy. Total loss to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €4.83 per share.
New Risk • Mar 30New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 42% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (42% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.3% net profit margin).
分析記事 • Mar 29GVS S.p.A. (BIT:GVS) Just Reported, And Analysts Assigned A €5.16 Price TargetIt's been a good week for GVS S.p.A. ( BIT:GVS ) shareholders, because the company has just released its latest...
Buy Or Sell Opportunity • Mar 16Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.8% to €3.43. The fair value is estimated to be €4.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.6% over the last 3 years. Earnings per share has declined by 5.4%. Revenue is forecast to grow by 10% in 2 years. Earnings are forecast to grow by 122% in the next 2 years.
New Risk • Nov 29New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 56% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (56% net debt to equity). Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results.
分析記事 • Nov 23We Like GVS' (BIT:GVS) Earnings For More Than Just Statutory ProfitGVS S.p.A.'s ( BIT:GVS ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...
分析記事 • Nov 15Earnings Report: GVS S.p.A. Missed Revenue Estimates By 8.1%Investors in GVS S.p.A. ( BIT:GVS ) had a good week, as its shares rose 3.0% to close at €4.33 following the release of...
Reported Earnings • Nov 14Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: €104.8m (down 1.9% from 3Q 2024). Net income: €7.98m (up €7.46m from 3Q 2024). Profit margin: 7.6% (up from 0.5% in 3Q 2024). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Italy.
New Risk • Nov 13New major risk - Revenue and earnings growthEarnings have declined by 35% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).
New Risk • Oct 23New major risk - Revenue and earnings growthEarnings have declined by 35% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).
分析記事 • Oct 23GVS (BIT:GVS) Will Want To Turn Around Its Return TrendsWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Major Estimate Revision • Oct 22Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €448.1m to €443.3m. EPS estimate also fell from €0.112 per share to €0.101 per share. Net income forecast to grow 136% next year vs 19% growth forecast for Medical Equipment industry in Italy. Consensus price target down from €6.23 to €6.05. Share price fell 9.9% to €4.19 over the past week.
分析記事 • Sep 16Calculating The Fair Value Of GVS S.p.A. (BIT:GVS)Key Insights Using the 2 Stage Free Cash Flow to Equity, GVS fair value estimate is €4.64 With €4.97 share price, GVS...
New Risk • Sep 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).
分析記事 • Aug 10GVS S.p.A. (BIT:GVS) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?BIT:GVS 1 Year Share Price vs Fair Value Explore GVS's Fair Values from the Community and select yours It's been a good...
Reported Earnings • Aug 10Second quarter 2025 earnings released: €0.005 loss per share (vs €0.055 profit in 2Q 2024)Second quarter 2025 results: €0.005 loss per share (down from €0.055 profit in 2Q 2024). Revenue: €112.1m (up 1.2% from 2Q 2024). Net loss: €880.0k (down 109% from profit in 2Q 2024). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Medical Equipment industry in Italy. Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 20% per year.
Major Estimate Revision • Jul 11Consensus EPS estimates fall by 28%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €458.6m to €452.6m. EPS estimate also fell from €0.27 per share to €0.196 per share. Net income forecast to grow 66% next year vs 24% growth forecast for Medical Equipment industry in Italy. Consensus price target of €6.38 unchanged from last update. Share price fell 3.8% to €5.35 over the past week.
お知らせ • Jul 08GVS S.p.A. (BIT:GVS) commences an Equity Buyback Plan for 37,835,539 shares, representing 20% of its issued share capital, under the authorization approved on May 8, 2025.GVS S.p.A. (BIT:GVS) commences a share repurchases on July 1, 2025, under the program mandated by the shareholders in the Ordinary General Meeting held on May 8, 2025. As per the mandate, the company is authorized to repurchase 37,835,539 shares in such a way that the maximum number of shares purchased may not have a total nominal value in excess of 20% of the company’s share capital. The shares will be repurchased at a unit price of not lower than 20% below and not higher than 10% above the reference price that the share will have recorded in the trading session of the day preceding each individual transaction. The purpose of the program is to support market liquidity and efficiency, for holding and subsequent use, including, payment in extraordinary transactions and for the use in service of compensation plans based on financial instruments. The authorization will be valid for a period of 18 months. As of March 24, 2025, the company had 189,177,693 shares in outstanding and held no shares in treasury. On June 30, 2025, the company announced a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.1% of the share capital, for €20 million. The program will commence from July 1, 2025 and will run through December 31, 2025.
Buy Or Sell Opportunity • Jun 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to €4.84. The fair value is estimated to be €3.95, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.2% over the last 3 years. Earnings per share has declined by 31%. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 114% in the next 2 years.
分析記事 • Jun 11Here's Why GVS (BIT:GVS) Can Manage Its Debt ResponsiblyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • May 24Shareholders Will Be Pleased With The Quality of GVS' (BIT:GVS) EarningsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week was disappointing for investors, despite the decent profit...
New Risk • May 22New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 50% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (50% net debt to equity). Large one-off items impacting financial results.
Reported Earnings • Apr 21Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: €0.19 (up from €0.078 in FY 2023). Revenue: €428.5m (flat on FY 2023). Net income: €33.4m (up 145% from FY 2023). Profit margin: 7.8% (up from 3.2% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 18%. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Mar 28Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €4.12, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 12x in the Machinery industry in Italy. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €3.26 per share.
分析記事 • Mar 28Should You Think About Buying GVS S.p.A. (BIT:GVS) Now?GVS S.p.A. ( BIT:GVS ), might not be a large cap stock, but it received a lot of attention from a substantial price...
分析記事 • Feb 24These 4 Measures Indicate That GVS (BIT:GVS) Is Using Debt Reasonably WellThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
お知らせ • Feb 22GVS S.p.A. to Report Q3, 2025 Results on Nov 12, 2025GVS S.p.A. announced that they will report Q3, 2025 results on Nov 12, 2025
お知らせ • Feb 21+ 2 more updatesGVS S.p.A. to Report Fiscal Year 2024 Results on Mar 24, 2025GVS S.p.A. announced that they will report fiscal year 2024 results on Mar 24, 2025
分析記事 • Feb 08Calculating The Fair Value Of GVS S.p.A. (BIT:GVS)Key Insights The projected fair value for GVS is €4.49 based on 2 Stage Free Cash Flow to Equity With €4.54 share...
New Risk • Jan 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (87% net debt to equity). Share price has been volatile over the past 3 months (5.5% average weekly change). Large one-off items impacting financial results.
お知らせ • Jan 15GVS S.p.A. (BIT:GVS) completed the acquisition of Whole Blood Assets within Blood Center Business from Haemonetics Corporation (NYSE:HAE).GVS S.p.A. (BIT:GVS) entered into a definitive agreement to acquire Whole Blood Assets within Blood Center Business from Haemonetics Corporation (NYSE:HAE) for $67.8 million on December 3, 2024. The transaction comprises a total cash consideration of up to $67.8 million, including $45.3 million upfront after giving effect to certain customary adjustments, and up to $22.5million in contingent earn-outs over the next four years. Haemonetics Corporation intends to use the proceeds from this transaction for general corporate purposes and additional investments in growth initiatives. The Transaction will be funded using available cash resources. This transaction is subject to the satisfaction of customary closing conditions and is expected to close in the first quarter of calendar 2025. Banca Sella Holding S.p.A.acted as sole financial advisor and Cleary Gottlieb Steen & Hamilton LLP acted as legal counsel to GVS. GVS S.p.A. (BIT:GVS) completed the acquisition of Whole Blood Assets within Blood Center Business from Haemonetics Corporation (NYSE:HAE) on December 3, 2024.
分析記事 • Jan 11Revenues Tell The Story For GVS S.p.A. (BIT:GVS)GVS S.p.A.'s ( BIT:GVS ) price-to-sales (or "P/S") ratio of 1.9x may not look like an appealing investment opportunity...
分析記事 • Dec 22What Is GVS S.p.A.'s (BIT:GVS) Share Price Doing?While GVS S.p.A. ( BIT:GVS ) might not have the largest market cap around , it saw significant share price movement...
Buy Or Sell Opportunity • Dec 18Now 21% overvaluedOver the last 90 days, the stock has fallen 20% to €5.20. The fair value is estimated to be €4.28, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 254% in the next 2 years.
分析記事 • Dec 07Returns On Capital Signal Tricky Times Ahead For GVS (BIT:GVS)If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
分析記事 • Nov 22GVS' (BIT:GVS) Solid Earnings Are Supported By Other Strong FactorsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week was disappointing for investors, despite the decent profit...
Reported Earnings • Nov 17Third quarter 2024 earnings released: EPS: €0.003 (vs €0.049 in 3Q 2023)Third quarter 2024 results: EPS: €0.003 (down from €0.049 in 3Q 2023). Revenue: €111.5m (up 12% from 3Q 2023). Net income: €519.0k (down 94% from 3Q 2023). Profit margin: 0.5% (down from 8.5% in 3Q 2023). Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.
分析記事 • Oct 23GVS S.p.A. (BIT:GVS) Shares Could Be 34% Above Their Intrinsic Value EstimateKey Insights GVS' estimated fair value is €4.67 based on 2 Stage Free Cash Flow to Equity GVS is estimated to be 34...
分析記事 • Oct 02Getting In Cheap On GVS S.p.A. (BIT:GVS) Is UnlikelyWhen close to half the companies in the Machinery industry in Italy have price-to-sales ratios (or "P/S") below 0.7x...
New Risk • Sep 13New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.9x net interest cover). Minor Risk Large one-off items impacting financial results.
Reported Earnings • Sep 13Second quarter 2024 earnings released: EPS: €0.056 (vs €0.027 in 2Q 2023)Second quarter 2024 results: EPS: €0.056 (up from €0.027 in 2Q 2023). Revenue: €114.7m (up 4.9% from 2Q 2023). Net income: €9.58m (up 100% from 2Q 2023). Profit margin: 8.4% (up from 4.4% in 2Q 2023). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance.
分析記事 • Sep 04Returns On Capital At GVS (BIT:GVS) Paint A Concerning PictureFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
お知らせ • Jul 26+ 2 more updatesGVS S.p.A. to Report Q3, 2024 Results on Nov 14, 2024GVS S.p.A. announced that they will report Q3, 2024 results on Nov 14, 2024
分析記事 • Jun 28Is GVS (BIT:GVS) A Risky Investment?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Price Target Changed • Jun 10Price target increased by 9.4% to €6.97Up from €6.37, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of €7.00. Stock is up 14% over the past year. The company is forecast to post earnings per share of €0.22 for next year compared to €0.078 last year.
分析記事 • Jun 09Investors Appear Satisfied With GVS S.p.A.'s (BIT:GVS) Prospects As Shares Rocket 28%GVS S.p.A. ( BIT:GVS ) shares have had a really impressive month, gaining 28% after a shaky period beforehand. Taking a...
分析記事 • Jun 08Should You Investigate GVS S.p.A. (BIT:GVS) At €7.00?GVS S.p.A. ( BIT:GVS ), is not the largest company out there, but it led the BIT gainers with a relatively large price...
New Risk • Jun 04New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 76% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (76% net debt to equity). Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €6.90, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 50% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €3.72 per share.
Reported Earnings • May 16First quarter 2024 earnings released: EPS: €0.074 (vs €0.015 in 1Q 2023)First quarter 2024 results: EPS: €0.074 (up from €0.015 in 1Q 2023). Revenue: €105.2m (up 1.1% from 1Q 2023). Net income: €13.0m (up 411% from 1Q 2023). Profit margin: 12% (up from 2.4% in 1Q 2023). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 24GVS S.p.A. to Report Q1, 2024 Results on May 14, 2024GVS S.p.A. announced that they will report Q1, 2024 results on May 14, 2024
分析記事 • Apr 21Earnings Tell The Story For GVS S.p.A. (BIT:GVS)With a price-to-earnings (or "P/E") ratio of 72.7x GVS S.p.A. ( BIT:GVS ) may be sending very bearish signals at the...
Major Estimate Revision • Apr 14Consensus EPS estimates increase by 27%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from €0.182 to €0.231. Revenue forecast steady at €445.0m. Net income forecast to grow 195% next year vs 9.1% growth forecast for Machinery industry in Italy. Consensus price target of €6.37 unchanged from last update. Share price fell 2.9% to €5.96 over the past week.
分析記事 • Apr 03Some Investors May Be Willing To Look Past GVS' (BIT:GVS) Soft EarningsGVS S.p.A.'s ( BIT:GVS ) earnings announcement last week didn't impress shareholders. Despite the soft profit numbers...
New Risk • Mar 30New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 51% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.0x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.2% net profit margin).
分析記事 • Mar 29GVS S.p.A. (BIT:GVS) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This YearThere's been a notable change in appetite for GVS S.p.A. ( BIT:GVS ) shares in the week since its yearly report, with...
New Risk • Mar 28New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.5x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (3.1% net profit margin).
分析記事 • Mar 26Capital Allocation Trends At GVS (BIT:GVS) Aren't IdealIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
お知らせ • Feb 26GVS S.p.A. to Report Fiscal Year 2023 Results on Mar 26, 2024GVS S.p.A. announced that they will report fiscal year 2023 results on Mar 26, 2024
分析記事 • Feb 23GVS (BIT:GVS) Has A Pretty Healthy Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Dec 15Be Wary Of GVS (BIT:GVS) And Its Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
Reported Earnings • Nov 12Third quarter 2023 earnings released: EPS: €0.048 (vs €0.072 in 3Q 2022)Third quarter 2023 results: EPS: €0.048 (down from €0.072 in 3Q 2022). Revenue: €104.4m (down 2.6% from 3Q 2022). Net income: €8.49m (down 33% from 3Q 2022). Profit margin: 8.1% (down from 12% in 3Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 135 percentage points per year, which is a significant difference in performance.
お知らせ • Oct 11GVS S.p.A. to Report Q3, 2023 Results on Nov 09, 2023GVS S.p.A. announced that they will report Q3, 2023 results on Nov 09, 2023
分析記事 • Sep 27GVS S.p.A. (BIT:GVS) Shares Could Be 33% Above Their Intrinsic Value EstimateKey Insights GVS' estimated fair value is €3.60 based on 2 Stage Free Cash Flow to Equity GVS is estimated to be 33...
Reported Earnings • Sep 07Second quarter 2023 earnings released: EPS: €0.025 (vs €0.11 in 2Q 2022)Second quarter 2023 results: EPS: €0.025 (down from €0.11 in 2Q 2022). Revenue: €111.9m (up 31% from 2Q 2022). Net income: €4.79m (down 76% from 2Q 2022). Profit margin: 4.3% (down from 23% in 2Q 2022). Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Machinery industry in Italy. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 127 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 08GVS S.p.A. to Report Q2, 2023 Results on Sep 05, 2023GVS S.p.A. announced that they will report Q2, 2023 results on Sep 05, 2023
分析記事 • Aug 02GVS (BIT:GVS) Might Be Having Difficulty Using Its Capital EffectivelyWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Price Target Changed • May 23Price target increased by 8.7% to €6.63Up from €6.10, the current price target is an average from 4 analysts. New target price is 16% above last closing price of €5.72. Stock is down 24% over the past year. The company is forecast to post earnings per share of €0.19 for next year compared to €0.14 last year.
Reported Earnings • May 16First quarter 2023 earnings released: EPS: €0.014 (vs €0.072 in 1Q 2022)First quarter 2023 results: EPS: €0.014 (down from €0.072 in 1Q 2022). Revenue: €105.0m (up 29% from 1Q 2022). Net income: €2.50m (down 80% from 1Q 2022). Profit margin: 2.4% (down from 16% in 1Q 2022). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Machinery industry in Italy.
Price Target Changed • Apr 30Price target increased by 8.7% to €6.63Up from €6.10, the current price target is an average from 3 analysts. New target price is 7.4% above last closing price of €6.18. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.20 for next year compared to €0.14 last year.
分析記事 • Apr 14Returns At GVS (BIT:GVS) Are On The Way UpIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Valuation Update With 7 Day Price Move • Mar 28Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €5.44, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 12x in the Machinery industry in Italy. Total loss to shareholders of 32% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €2.63 per share.
Reported Earnings • Mar 22Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: €0.27 (down from €0.39 in FY 2021). Revenue: €392.0m (up 15% from FY 2021). Net income: €46.5m (down 31% from FY 2021). Profit margin: 12% (down from 20% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 38%. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Machinery industry in Italy.
Price Target Changed • Jan 23Price target increased to €6.55Up from €5.50, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €5.04. Stock is down 46% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €0.39 last year.
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improved over the past weekAfter last week's 16% share price gain to €4.91, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 12x in the Machinery industry in Italy. Total loss to shareholders of 50% over the past year.
Valuation Update With 7 Day Price Move • Dec 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to €4.02, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 62% over the past year.
分析記事 • Dec 10GVS (BIT:GVS) Will Want To Turn Around Its Return TrendsThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 4 independent directors (5 non-independent directors). Executive Director Matteo Viola was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
分析記事 • Nov 11Calculating The Fair Value Of GVS S.p.A. (BIT:GVS)How far off is GVS S.p.A. ( BIT:GVS ) from its intrinsic value? Using the most recent financial data, we'll take a look...
Valuation Update With 7 Day Price Move • Nov 10Investor sentiment deteriorated over the past weekAfter last week's 38% share price decline to €3.00, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Machinery industry in Italy. Total loss to shareholders of 72% over the past year.
Reported Earnings • Sep 11Second quarter 2022 earnings released: EPS: €0.11 (vs €0.096 in 2Q 2021)Second quarter 2022 results: EPS: €0.11 (up from €0.096 in 2Q 2021). Revenue: €85.3m (down 1.5% from 2Q 2021). Net income: €19.8m (up 18% from 2Q 2021). Profit margin: 23% (up from 19% in 2Q 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Machinery industry in Italy.
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €7.69, the stock trades at a trailing P/E ratio of 27.5x. Average forward P/E is 10x in the Machinery industry in Italy. Total loss to shareholders of 52% over the past year.
分析記事 • Aug 30Here's What's Concerning About GVS' (BIT:GVS) Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
分析記事 • Jul 28At €9.05, Is GVS S.p.A. (BIT:GVS) Worth Looking At Closely?While GVS S.p.A. ( BIT:GVS ) might not be the most widely known stock at the moment, it saw a significant share price...
分析記事 • Jul 13Investor Optimism Abounds GVS S.p.A. (BIT:GVS) But Growth Is LackingGVS S.p.A.'s ( BIT:GVS ) price-to-earnings (or "P/E") ratio of 30.4x might make it look like a strong sell right now...
